EXAS Financial Facts
General and administrative: 20.29MTotal Operating expenses: 54.23M
See Full Income Statement
TOTAL ASSETS: 403.21M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY: 403.21M
See Full Balance Sheet
Exact Sciences (EXAS) Earnings
|
Expand Research on EXAS
| Next EPS Date | 5/8/24 | EPS Growth Rate | -14.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +46.5% | Revenue Growth Rate | +4.1% |
| Average % Move 1-Wk after EPS | -2.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/24  |
Q124 | N/A | -$0.48 | N/A | N/A | $627.15M | = | N/A | N/A | ||
| 2/21/24 | Q423 | -$0.27 | -$0.44 | +$0.17 | $647M | $637.34M | = |  | | Details | |
| 11/1/23 | Q323 | $0.00 | -$0.47 | +$0.47 | $628M | $616.79M | = | | | Details | |
| 8/1/23 | Q223 | -$0.45 | -$0.47 | +$0.02 | $622.1M | $601.14M | = | | | Details | |
| 5/9/23 | Q123 | -$0.42 | -$0.74 | +$0.32 | $602.45M | $543.29M | = | | | Details | |
| 2/21/23 | Q422 | -$0.72 | -$0.79 | +$0.07 | $553M | $524.51M | = | | | Details | |
| 11/3/22 | Q322 | -$0.84 | -$1.07 | +$0.23 | $523.1M | $503.13M | = | | | Details | |
| 8/2/22 | Q222 | -$0.94 | -$1.05 | +$0.11 | $522M | $497.18M | = | | | Details |
